skip to Main Content

Intermittent fasting interventions to leverage metabolic and circadian mechanisms for cancer treatment and supportive care outcomes

Intermittent fasting entails restricting food intake during specific times of day, days of the week, religious practice, or surrounding clinically important events. Herein, the metabolic and circadian rhythm mechanisms underlying the proposed benefits of intermittent fasting for the cancer population are described. We summarize epidemiological, preclinical, and clinical studies in cancer published between January 2020 and August 2022 and propose avenues for future research. An outstanding concern regarding the use of intermittent fasting among cancer patients is that fasting often results in caloric restriction, which can put patients already prone to malnutrition, cachexia, or sarcopenia at risk. Although clinical trials do not yet provide sufficient data to support the general use of intermittent fasting in clinical practice, this summary may be useful for patients, caregivers, and clinicians who are exploring intermittent fasting as part of their cancer journey for clinical outcomes and symptom management.

Authors: Kalam, Faiza;James, Dara L;Li, Yun Rose;Coleman, Michael F;Kiesel, Violet A;Cespedes Feliciano, Elizabeth M;Hursting, Stephen D;Sears, Dorothy D;Kleckner, Amber S

J Natl Cancer Inst Monogr. 2023 May 04;2023(61):84-103.

PubMed abstract

Explore all studies and publications

Back To Top